docetaxel anhydrous has been researched along with Coronary Artery Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crivellari, D; Goldhirsch, A; Graffeo, R; Hess, D; Lombardi, D; Longhi, S; Munzone, E; Nolè, F; Pagani, O; Ruggeri, M; Sessa, C; Thürlimann, B | 1 |
| Reddy, HK; Sturek, M | 1 |
1 trial(s) available for docetaxel anhydrous and Coronary Artery Stenosis
| Article | Year |
|---|---|
Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cardiomyopathy, Dilated; Coronary Stenosis; Deoxycytidine; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Maximum Tolerated Dose; Middle Aged; Taxoids; Treatment Outcome | 2005 |
1 other study(ies) available for docetaxel anhydrous and Coronary Artery Stenosis
| Article | Year |
|---|---|
New tools for prevention of restenosis could decrease the "oculo-stento" reflex.
Topics: Angioplasty, Balloon, Coronary; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Coronary Restenosis; Coronary Stenosis; Docetaxel; Drug Implants; Humans; Injections, Intra-Arterial; Models, Animal; Paclitaxel; Rabbits; Rats; Sirolimus; Stents; Taxoids | 2002 |